🇺🇸 FDA
Patent

US 8946444

Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control

granted A61KA61K31/343A61K31/403

Quick answer

US patent 8946444 (Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control) held by PTC THERAPEUTICS, INC. expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/343, A61K31/403, A61K31/4035, A61K31/407